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Introduction
Vaccine safety monitoring is an essential component of immunisation programs
that aims to provide reassurance to the community and health care workers of the
safety of vaccines and to enable potential safety signal detection. Pre-marketing
vaccine safety studies are generally conducted on healthy participants; postmarketing surveillance should include groups who are underrepresented in vaccine
clinical trials. This may include younger and older age-groups, people with
underlying health conditions and minority groups. Participant-centred active
Adverse Event Following Immunisation (AEFI) surveillance is increasingly
recognised as an efficient way of contacting vaccine recipients and directly
gathering data on their near real-time vaccine experience (Cashman et al., 2017;
Pillsbury et al., 2017).
In Australia, there have been substantial and long-standing gaps in health
outcomes between Aboriginal and Torres Strait Islander People (hereafter
respectfully called Aboriginal People) and the rest of the population (Holland,
2018). This is well described for vaccine-preventable diseases (Naidu et al, 2013).
During the 2009 influenza pandemic, Aboriginal people, particularly those in
regional and remote communities, were found to experience higher morbidity and
mortality than non-Aboriginal people in Australia (Kelly, Mercer and Cheng,
2009). The primary barrier for Aboriginal people receiving the influenza vaccine is
concern about the potential side effects (Wolstenholme, Duffy and Smith, 2017).
Thus, concerns about safety, which might hamper vaccine uptake, should be
actively allayed.
It is essential to ensure Aboriginal involvement in active AEFI surveillance,
so that trust can be built. Supporting Aboriginal involvement in AEFI surveillance
is an important component in building trust in vaccination. The advent of improved
personal communication and access to smartphones and email has enabled active
engagement and direct involvement with community members before (such as precall systems) and after immunisation. Immunised individuals or their carers are
actively canvassed for their own experience following immunisation, which has
facilitated adverse event data collection but also has the potential to make vaccine
safety more transparent for consumers. To enhance AEFI surveillance, we
developed an active web-based participant-centred vaccine safety monitoring
system called Vaxtracker, which is an active member of the AusVaxSafety
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consortium. Vaxtracker aims to detect signals indicating a possible vaccine safety
issue by sending a SMS (short message service) and/or email three days after
immunisation. Clicking or tapping on the embedded link allows completion of an
online survey.
In 2015, Aboriginal children aged six months to less than five years of age
became eligible for funded seasonal influenza vaccine under the Australian
National Immunisation Program (NIP) and in 2016 a diphtheria, tetanus and
acellular pertussis (DTPa) booster vaccine was introduced for all 18-month-old
children. Both changes were accompanied by enhanced vaccine safety surveillance
through the national AusVaxSafety consortium, in which Vaxtracker participates.
These changes to the NIP provided the opportunity to better understand
participation of Aboriginal people in the active AEFI surveillance and explore
factors that may impact on their participation.
Methods
At the time of immunisation with either the influenza or DTPa vaccine, children’s
parents or carers were asked by practice or clinic health staff if they would like to
participate in the Vaxtracker program. Links to the online survey were sent via the
contact method chosen by the parent or carer (email and/or SMS). Written
information describing the Vaxtracker program was available for parents. A
welcome message was sent one day after the immunisation and the link to the
survey followed three days after the immunisation. If there was no response to the
survey after three days, then two automated reminders were sent three days apart
on days six and nine post immunisation. Twenty-three general practices, four
Aboriginal Medical Services (AMS) and one Community Health Centre in the
Hunter New England Local Health District, New South Wales, Australia, enrolled
parents and carers of vaccinated children into the study.
To explore potential barriers to participation in automated active AEFI
surveillance, Aboriginal Immunisation Officers attempted to interview all parents
or carers of children who did not respond to the Vaxtracker surveys. Families whose
children had a vaccination date from 5 April to 24 October 2016 where included in
this study.
Two questionnaires were used during the follow-up interviews by the
Aboriginal Immunisation Officers. Firstly, the Vaxtracker AEFI questionnaire was
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used only with Aboriginal parents who did not respond to the influenza vaccine
online survey. This AEFI survey was modified to ensure the language was more
suitable for a person to person telephone interview. The demographic and AEFI
data gathered telephonically were manually entered by the study interviewer into
the Vaxtracker web-based program to add to the data already collected from the
web-based influenza vaccine questionnaire from the online parental responders.
The second person-to-person telephone questionnaire (Evaluation Questionnaire)
explored possible barriers to accessing Vaxtracker for Aboriginal and nonAboriginal participants for both the influenza and DTPa vaccines. These responses
were collated separately in an MS Excel spreadsheet.
Training was provided for two Aboriginal Immunisation Officers on
interviewing people using the two questionnaires, data entry on the Vaxtracker and
MS Excel, and the referral process to a public health clinician for appropriate follow
up if an adverse event was reported.
Aboriginal Immunisation Officers attempted to contact parents and carers
who had not completed the online automated survey ten days after their vaccination
date with three phone call attempts and/or three email attempts made for each
family. These contact attempts were made over a one-week period, at different
times of the day. Messages were left if there was a voice mail service available.
Once 28 days had lapsed since vaccination, no further contact was attempted. Phone
calls were made from an ‘unblocked’ land line number so that the phone number
was visible to phone call recipient. The protocol used for this study is available
from the authors.
Data collected as part of the study was analysed in Stata 15 Statistical
Package. Basic descriptive analysis was conducted on each vaccine program
individually.
In Australia, health professionals are required to report adverse event
following immunisation to the Therapeutic Goods Administration (TGA) and State
and Territory Health Departments. The follow-up of people who did not respond to
the automated survey was considered a quality improvement activity to assess the
impact of AEFI surveillance and was authorised as a non-research activity by the
Hunter New England Human Research Ethics Committee Authorisation Number
AU201506-3.
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Results
There was a differential response rate for both vaccines between Aboriginal and
non-Aboriginal enrolees, with statistically significantly lower responses from
Aboriginal parents for both vaccines (Table 1). The methods of response were
similar for Aboriginal and non-Aboriginal families using the link to the online
survey from both email and SMS (Table 1).
For Aboriginal children, those enrolled through a general (family) practice
were more likely to respond than those enrolled through an Aboriginal Medical
Service. There was no significant difference in the age distribution of the children
from six months to under five years for families who responded.
Aboriginal immunisation officers were able to contact the non-responding
parents or carers of 25 of the 53 Aboriginal children in 50 Aboriginal families
(47.2%) and 31 of the 122 non-Aboriginal children (25.4%) in 105 non-Aboriginal
families. The parents or carers of 119 children (Aboriginal children n=28 in 26
families, non-Aboriginal children n=91 in 77 families) were either unable to be
contacted or 28 days had elapsed since the vaccination. The most common reason
for not being contacted was that 28 days had passed since the vaccination
(Aboriginal n=13/28, non-Aboriginal n=75/91). Other reasons included that the
phone number was incorrect (Aboriginal n=7, non-Aboriginal n=3) and lost to
follow-up by having three unanswered calls (Aboriginal n=6, non-Aboriginal n=4).
One of the 12 interviews of parent/carers who did not respond to the online
survey after influenza immunisation of an Aboriginal child reported a localised
reaction (8.3%) during this follow-up study. This rate was low compared to 22%
(36/167) of people responding to the automated online influenza vaccine AEFI
survey.
During the follow-up telephone interviews regarding reasons for nonresponse, the interviewers allocated responses into categories. The most common
reason provided by both Aboriginal and non-Aboriginal parent/carers for not
completing the survey was being “too busy” (50.0% and 75% respectively) (Table
2). Technological issues such as problems with the mobile telephone or the network
were more common among Aboriginal non-responders 33.3% compared to 7.1%.
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Table 1: Vaxtracker AEFI survey responses by Parents and Carers of
Aboriginal and non-Indigenous children, for Influenza and DTPa
vaccine in 2016
Influenza
No. (%)

DTPa
P value4

No. of parents/carers agreeing to
193
participate in Vaxtracker:

No. (%)

568

• Representing Aboriginal children

55 (28.5)

78 (13.7)

• Representing
children

138
(71.5)

490
(86.3)

No of surveys completed (by
150
parents
and
Aboriginal
(77.7)
Immunisation Officers)

432
(76.1)

No of surveys completed (by 137
parents)
(71.0)

426
(75.0)

non-Indigenous

Survey
completion
1
Aboriginality

by

31
(56.4)
0.005
106
• Parents/carers:
non-Indigenous
(76.8)
children
Preferred contact method selected by participants
• Parents/carers: Aboriginal children

• Parents/carers:
Aboriginal children

43
(55.1)
383
(78.2)

Both

21 (38.2)

33 (42.3)

Email
only

2 (3.6)

0 (0.0)

SMS only 32 (58.2)
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• Parents/carers: non- Both
Indigenous children
Email
only

83 (60.1)

396
(80.8)

7 (5.1)

27 (5.5)

SMS only 48 (34.1)

67 (13.7)

Response rate by method 1
• Parents/carers:
Aboriginal children

Email

10 (30.3)

12 (52.2)

SMS

21 (39.6)

31 (39.7)

52
(57.8%)

176
(41.6)

0.381

• Parents/carers: non- Email
Indigenous children
SMS

0.289

0.015
54
(41.2%)

0.352
207
(44.7)

Response rate by clinic type: Aboriginal children1
• Aboriginal Medical Service
• General Practice
• Community Health

12
(52.2)
19
(59.4)

0.595

N/A4

14
(36.9)
8
(100.0)
21
(65.6)

0.001

147
(87.0)
236
(73.5)

0.001

Response rate by clinic type: non-Indigenous children1
• General Practice
• Community Health

106
(76.8)
N/A3

Notes: 1. Surveys completed by parents only, does not include surveys completed by Aboriginal
Immunisation Officers
2. DTPa Vaxtracker is an ongoing program. Children with a vaccination date from 5/424/10/2016 were included in this study
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Table 2: Reasons provided for not responding to the Vaxtracker AEFI surveys
elicited during follow-up interview, by Aboriginality

Too busy

Parents/carers of
Aboriginal
children (N=24)

Parents/carers of
non-Aboriginal
children (N=28)

n (%)

n (%)

12 (50.0)

Forgot

4 (16.7)

No credit available

3 (12.5)

No specific reason

4 (16.7)

Too busy/forgot

13 (54.2)

Technical
issues
8 (33.3)
(user/device/network)

Technical issues (all)

1

10 (41.7)

RR
(95%
CI)

P
value

21 (75.0)

0.58
(0.33- 0.062
1.02

15 (53.6)

0.35
(0.14- 0.006
0.87)

1 (3.6)

1.71
(0.89- 0.228
3.29)

2 (7.1)

1.53
(0.80- 0.284
2.95)

23 (82.1)

0.53
(0.30- 0.029
0.91

2 (7.1)

2.1
(1.28- 0.017
3.44)

3 (10.7)

2.1
(1.28- 0.010
3.58)

Multiple responses per participant possible
1.

Includes all user and device technical issues including no credit
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Discussion
There are many gaps in health outcomes between Aboriginal people and the rest of
the Australian population, which we also found in this study of the early use of
participant-centred AEFI surveillance. There was a differential response rate for
both vaccines’ online AEFI surveys between Aboriginal and non-Aboriginal
enrolees.
In interpreting these findings, it is important that the following limitations
are considered. The sample size was small, and the interviewers were not blinded.
Responses to telephone surveys may have provided relatively superficial reasons
rather than when these are explored in-depth in person and some people may have
found the telephone survey confronting. As there was naturally a delay before
seeking reasons for not completing the survey, potentially up to 28 days, recall bias
may have been a factor. The study had no additional resourcing and delays in
making the telephone calls excluded a number of participants, in order to limit the
potential for recall bias.
We found that parents/carers were more likely to respond if they provided
both an email address and mobile phone number to the vaccination clinic. As
parents/carers of non-Aboriginal children were more likely to provide both contact
options when compared to the parents/carers of Aboriginal children, they would
have received twice the number of survey prompts and reminder messages, which
may have increased the opportunity of responding to a message (Australian
Ministers’ Advisory Council, 2017). When Aboriginal people nominated both SMS
and email, they were more likely to respond from the link sent by email (50%).
Both technologies are worth exploring to enable Aboriginal people to access health
information services, however, their preference should be monitored over time, as
this may be influenced by cost and availability of emerging technologies.
Response rates of the parents/carers of Aboriginal children who received
their vaccination at an Aboriginal Medical Service (AMS) were lower when
compared to those visiting a General Practice. We were unable to identify why this
difference exists. The Aboriginal and Torres Strait Islander Health Performance
Framework 2017 Report (Australian Ministers’ Advisory Council, 2017) found that
most Aboriginal and Torres Strait Islander people went to a doctor if they had a
health problem (54%), followed by Aboriginal Medical Services (AMS) (17%),
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with use of AMS and community clinics increasing from 13% in major cities to
66% in very remote areas. Aboriginal participants in this AEFI surveillance
followed a similar pattern with more outer regional and remote area participants
serviced by AMSs. Over 50% of Aboriginal people live in major cities or regional
centres (Marles, Frame and Royce, 2012). Our study area in the HNELHD in NSW
covers the city of Newcastle and regional areas of NSW but not very remote areas.
The relative geographic isolation of some Aboriginal families may explain the more
frequent mention of technical issues impacting on their ability to respond to online
surveys. Although general (family) practice may not have a high proportion of
Aboriginal clients it is an important place of care where active surveillance is
potentially useful and informative for Aboriginal people (Australian Ministers’
Advisory Council, 2017). Further strategies may be required to reach and canvas
Aboriginal people living in remote and very remote areas to ensure inclusion in
appropriately designed AEFI surveillance.
Although telephone credit was mentioned as a barrier by four respondents
(3 Aboriginal and 1 non-Aboriginal) it appears to be less of a barrier than was
anticipated following discussions with health professionals prior to the study.
Aboriginal people did report technology difficulties more than non-Aboriginal
people (41.7% cf 10.7%, p value 0.010), however, care should be taken when
interpreting these data, as numbers of participants are small. However, in a 2015
survey of Aboriginal women about immunisation during pregnancy in Western
Australia, over half of the 400 women sampled had a phone number that was
incorrect or not functional (Lotter et al., 2018). Mobile phones are an increasingly
efficient means of involving people in health and health data collection, but care is
required to ensure Aboriginal people are not excluded and are able to contribute
their experiences, in this case, vaccine adverse events. In 2017, the Aboriginal and
Torres Strait Islander participation in the national AusVaxSafety database was
2.0%, whereas Aboriginal and Torres Strait Islander people comprise 3.3% of the
Australian population (Pillsbury et al., 2018).
Young Aboriginal people are rapid adopters of new technologies, including
smartphones, which can facilitate participation in culturally important activities,
such family and community connectivity, but factors such as socioeconomic status
and remoteness may impact on uptake. A review of social media use by young
Aboriginal people concluded that future use could bridge health and education gaps
(Rice et al., 2016). The Menzies School of Health Research has successfully
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demonstrated the use of an app to prevent overconsumption of sugary drinks in
remote Communities in the Northern Territory (Tonkin et al., 2017). These case
studies suggest that use of new technology alone does not necessarily exclude
Aboriginal people. We recognise that deeper understanding is required on how to
best engage Aboriginal families in active AEFI surveillance and a qualitative study
using a “yarning circle” methodology may be worthwhile to ensure that current
inequality in health service provision is not perpetuated (Dunleavy, 2013).
Conclusion
There is growing recognition that active automated participant-based surveillance
is an important contributor to assess the post-marketing safety of vaccines
(Pillsbury et al., 2017). This method likely improves vaccine safety signal detection
and potentially contributes to better confidence in vaccines (Cashman et al., 2017;
Crawford et al., 2014). The response rates to the active AEFI surveillance in this
study were generally good in both non-Aboriginal and Aboriginal families, but
lower in the latter. Involving Aboriginal people in active AEFI surveillance is
critical to the surveillance of safety as new vaccines, for example pandemic
vaccines, are introduced in higher risk subpopulations, including First Nations
Peoples. Vaccine safety is a concern for some Aboriginal people (Wolstenholme,
Duffy and Smith, 2017) so all the more important that Aboriginal people have the
opportunity to participate in active AEFI surveillance and thus it is important that
barriers to their participation are better understood and overcome.
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